Microbial biomarker discovery in Parkinson's disease through a network-based approach

Area of Science:

• Microbiology
• Neuroscience
• Genetics

Background:

• Gut microbiota alterations are linked to Parkinson's disease (PD).
• Replicable diagnostic biomarkers for PD based on gut microbiome are still needed.
• Previous studies suggest a role for the gut microbiome in PD pathogenesis.

Purpose of the Study:

• To conduct a meta-analysis on the gut microbiome's role in PD.
• To identify potential diagnostic biomarkers for PD from gut microbial data.
• To explore functional pathways associated with gut microbiota changes in PD.

Main Methods:

• Integrated six 16S rRNA gene amplicon datasets from five studies (550 PD, 456 controls).
• Analyzed microbial composition, alpha and beta diversity.
• Utilized NetMoss algorithm for biomarker identification and developed a classification model.

Main Results:

• Significant alterations in gut microbial composition and diversity were observed in PD patients.
• Reduced abundance of butyrate-producing bacteria (e.g., Faecalibacterium, Roseburia) and increased Akkermansia and Bilophila in PD.
• A classification model based on 11 genera showed high performance for PD diagnosis.

Conclusions:

• The gut microbiome is significantly altered in Parkinson's disease.
• Specific microbial taxa may serve as potential biomarkers for PD diagnosis.
• Findings suggest gut microbiota modulation as a therapeutic target for PD.